Abstract
ObjectiveTo investigate the antimalarial activity and toxicity of the crude ethanolic extract of its pericarp both in vitro and in vivo. MethodsThe antimalarial activity of Garcinia mangostana (G. mangostana) Linn. extract against 3D7 and K1 Plasmodium falciparum (P. falciparum) clone were assessed using SYBR green I-based assay. A 4-day suppressive test of Plasmodium berghei (P. berghei) infected mouse was performed to investigate in vivo antimalarial activity. ResultsThe in vitro antimalarial activity was selective (SI > 5) and classified as weak and good to moderate activity against both 3D7 and K1 P. falciparum clones with median IC50 (range) values of 11.12 (10.94–11.29) and 7.54 (6.80–7.68) μg/mL, respectively. The extract was considered non-toxic to mice. The maximum tolerated doses for acute and subacute toxicity in mice were 5 000 and 2 000 mg/kg, respectively. Median (range) parasite density on day 4 of the negative control group (25% Tween-80), mice treated with 250, 500, 1 000, and 2 000 mg/kg body weight of the extract, and 10 mg/kg body weight of chloroquine for 14 d were 12.8 (12.2–13.7), 11.4 (9.49–13.8), 11.6 (9.9–12.5), 11.7 (10.6–12.8), 10.9 (9.4–11.6) and 0 (0–0)% respectively. Parasite density on day 4 in the control group treated with Tween-80 was higher than the groups treated with chloroquine and all dose levels of the extract. ConclusionsG. mangostana Linn. showed weak antimalarial activity of the extract both in vitro and in vivo could be due to limitation of absorption of the active compounds.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.